All articles by Vasanthi Vara

  1. Coronavirus in India: how the COVID-19 could impact the fast-growing economy

    Visit our COVID-19 microsite for the latest coronavirus news, analysis and updates GlobalData’s latest Coronavirus Influencers dashboard is now live on…
    Read More…

    30 Apr
  2. Covid-19 affecting both advanced and developing economies, according to macroeconomic influencers

    The rise in unemployment and economic impact caused by the COVID-19 pandemic is being witnessed across both advanced and developing…
    Read More…

    21 Apr
  3. Coronavirus outbreak: The countries affected

    Visit our COVID-19 microsite for the latest coronavirus news, analysis and updates GlobalData’s latest Coronavirus Influencers dashboard is now live on…
    Read More…

    16 Apr
  4. Coronavirus in the US: COVID-19 outbreak, measures and impact

    Visit our COVID-19 microsite for the latest coronavirus news, analysis and updates GlobalData’s latest Coronavirus Influencers dashboard is now live on…
    Read More…

    30 Mar
  5. Coronavirus: Countries with suspected cases

    Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates Follow the updates on coronavirus: Coronavirus-affected countries: List…
    Read More…

    26 Mar
  6. UK confirms first new coronavirus case; rises risk level

    The UK Department of Health and Social Care confirmed the first two cases of coronavirus infection in England. The two…
    Read More…

    31 Jan
  7. Cardiovascular: European Society of Cardiology tops Twitter Q3 2019

    Pharmaceutical Technology lists the top five terms tweeted in cardiovascular in Q3 2019, based on data from GlobalData’s Influencer Platform….
    Read More…

    24 Oct
  8. Top five most expensive drugs in the US

    The most expensive drugs in the US: Ranking the top five Spinraza (nusinersen) –$750,000 first year and $375,000 thereafter RAVICTI…
    Read More…

    24 Jun
  9. The world’s biggest pharmaceutical companies by revenue in 2018

    Johnson & Johnson – $62.9bn While the company has stakes in consumer markets, the majority of Johnson & Johnson’s (J&J)…
    Read More…

    20 Jun
Close
Close
Close

Go Top